Article Details
Retrieved on: 2024-05-16 14:13:52
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Elisabth Bik's critique of Didier Raoult's controversial study on hydroxychloroquine, a drug that Donald Trump endorsed for COVID-19 treatment. French authorities dismissed legal complaints against Bik, filed by Raoult, citing insufficient evidence.
Article found on: www.chemistryworld.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here